Clinical Feasibility Study of the BariTon™ System in Obese or Overweight Patients.

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

June 1, 2025

Conditions
Obesity
Interventions
DEVICE

Endoscopic gastric restriction and biliodigestive diversion

The BariTon™ is endoscopically implanted and retrieved once treatment is completed

Trial Locations (2)

2028

RECRUITING

BMI Clinic Double Bay, Sydney

2170

RECRUITING

BMI Clinic Liverpool, Sydney

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BariaTek Medical

INDUSTRY

NCT06360679 - Clinical Feasibility Study of the BariTon™ System in Obese or Overweight Patients. | Biotech Hunter | Biotech Hunter